Digital imaging

NDT and Inspection Market worth $18.4 billion by 2029- Exclusive Report by MarketsandMarkets™

Retrieved on: 
Thursday, February 15, 2024

The power Generation vertical of the NDT and Inspection market is predicted to register the highest market share between 2024-2029.

Key Points: 
  • The power Generation vertical of the NDT and Inspection market is predicted to register the highest market share between 2024-2029.
  • NDT and Inspection market for the Asia Pacific region to register the highest CAGR between 2024 and 2029 forecast.
  • The Asia Pacific region is poised to emerge as the fastest-growing market for NDT and inspection, driven by rapid infrastructural developments.
  • However, challenges such as pricing pressures pose a limitation to the growth of the NDT and inspection industry in Asia Pacific.

NDT and Inspection Market worth $18.4 billion by 2029- Exclusive Report by MarketsandMarkets™

Retrieved on: 
Thursday, February 15, 2024

The power Generation vertical of the NDT and Inspection market is predicted to register the highest market share between 2024-2029.

Key Points: 
  • The power Generation vertical of the NDT and Inspection market is predicted to register the highest market share between 2024-2029.
  • NDT and Inspection market for the Asia Pacific region to register the highest CAGR between 2024 and 2029 forecast.
  • The Asia Pacific region is poised to emerge as the fastest-growing market for NDT and inspection, driven by rapid infrastructural developments.
  • However, challenges such as pricing pressures pose a limitation to the growth of the NDT and inspection industry in Asia Pacific.

AbbaDox Joins Imaging AI in Practice Demonstration at RSNA 2023

Retrieved on: 
Thursday, November 16, 2023

AVENTURA, Fla., Nov. 16, 2023 /PRNewswire/ -- AbbaDox announced today that it will take part in the Imaging Artificial Intelligence in Practice (IAIP) demonstration to be held November 26 – 29 at the 109th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA 2023), the world's leading annual imaging forum, at McCormick Place in Chicago.

Key Points: 
  • AVENTURA, Fla., Nov. 16, 2023 /PRNewswire/ -- AbbaDox announced today that it will take part in the Imaging Artificial Intelligence in Practice (IAIP) demonstration to be held November 26 – 29 at the 109th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA 2023), the world's leading annual imaging forum, at McCormick Place in Chicago.
  • The IAIP demo is a showcase of new AI technologies and integration standards needed to embed AI into the diagnostic radiology workflow.
  • By incorporating AI into its RIS, AbbaDox demonstrates a significant leap in radiology practice, showcasing how AI can streamline referrals, pre-registration, scheduling, intake, dictation and reporting processes within the radiology domain.
  • "Integrating AI into our Radiology Information System is a game changer," said Pierre-Antoine Tricen, Head of Marketing, at AbbaDox.

Global X-Ray Detector Market to Reach $6.22 Billion by 2023, Growing at a CAGR of 6.02% - ResearchAndMarkets.com

Retrieved on: 
Thursday, November 2, 2023

By Application: The market report categorizes the x-ray detector market into four main applications: Medical, Industrial, Security, and Veterinary.

Key Points: 
  • By Application: The market report categorizes the x-ray detector market into four main applications: Medical, Industrial, Security, and Veterinary.
  • By Technology: X-ray detector technology is segmented into four categories: Flat panel detector, computed radiography, line scan detector, and CCD detector.
  • The global x-ray detector market is divided into five major regions: Asia Pacific, North America, Europe, Latin America, and Middle East & Africa.
  • Growing Geriatric Population: The increasing elderly population drives the demand for medical imaging procedures, contributing to the growth of the x-ray detector market.

Teledyne Technologies Reports Third Quarter Results

Retrieved on: 
Wednesday, October 25, 2023

Excluding these items, non-GAAP net income attributable to Teledyne for the third quarter of 2023 was $241.9 million ($5.05 diluted earnings per share).

Key Points: 
  • Excluding these items, non-GAAP net income attributable to Teledyne for the third quarter of 2023 was $241.9 million ($5.05 diluted earnings per share).
  • Excluding these items, non-GAAP net income attributable to Teledyne for the third quarter of 2022 was $216.5 million ($4.54 diluted earnings per share).
  • Operating margin was 18.8% for the third quarter of 2023, compared with 18.0% for the third quarter of 2022.
  • Teledyne received $12.2 million from the exercise of stock options in the third quarter of 2023 compared with $0.9 million.

Robert Mehrabian to be Named Executive Chairman; Edwin Roks, Chief Executive Officer; George Bobb, President and Chief Operating Officer

Retrieved on: 
Tuesday, October 24, 2023

The Board of Directors of Teledyne Technologies Incorporated (NYSE:TDY) announced today that Robert Mehrabian will be named Executive Chairman, effective January 1, 2024.

Key Points: 
  • The Board of Directors of Teledyne Technologies Incorporated (NYSE:TDY) announced today that Robert Mehrabian will be named Executive Chairman, effective January 1, 2024.
  • In addition, Edwin Roks will assume the role of Chief Executive Officer, and George C. Bobb III will assume the role of President and Chief Operating Officer.
  • Edwin Roks, current Executive Vice President of Teledyne, leads Teledyne’s Digital Imaging Segment and has gained increasing levels of operational responsibility, including the successful integration of Teledyne’s largest acquisitions.
  • “I want to congratulate Edwin and George on their well-deserved promotions to CEO and President and COO, respectively,” said Robert Mehrabian, Chairman, President and Chief Executive Officer.

DataForce Expands Offerings to Support AI-Powered Pathology Detection

Retrieved on: 
Wednesday, September 27, 2023

NEW YORK, Sept. 27, 2023 /PRNewswire/ -- DataForce, TransPerfect's AI data solutions division, today announced its platform support for Digital Imaging and Communication in Medicine (DICOM), which simplifies the process of identifying pathologies or diseases. The new tool processes and annotates medical data provided by pharmaceutical and biotechnology organizations that utilize artificial intelligence.

Key Points: 
  • NEW YORK, Sept. 27, 2023 /PRNewswire/ -- DataForce , TransPerfect's AI data solutions division, today announced its platform support for Digital Imaging and Communication in Medicine (DICOM), which simplifies the process of identifying pathologies or diseases.
  • The new tool processes and annotates medical data provided by pharmaceutical and biotechnology organizations that utilize artificial intelligence.
  • Pharmaceutical, biotechnology and medical device sponsors as well as pathology and diagnostic companies can partner with DataForce to label their datasets and train machine learning models used in applications such as early pathology detection, fast diagnostics, and accelerated product development.
  • Xavier Fort, Vice President of DataForce, shared, "We are thrilled to launch DataForce's DICOM support as it will accelerate progress in the assessment, treatment, and ultimately cures for patients."

DataForce Expands Offerings to Support AI-Powered Pathology Detection

Retrieved on: 
Wednesday, September 27, 2023

NEW YORK, Sept. 27, 2023 (GLOBE NEWSWIRE) -- DataForce , TransPerfect’s AI data solutions division, today announced its platform support for Digital Imaging and Communication in Medicine (DICOM), which simplifies the process of identifying pathologies or diseases.

Key Points: 
  • NEW YORK, Sept. 27, 2023 (GLOBE NEWSWIRE) -- DataForce , TransPerfect’s AI data solutions division, today announced its platform support for Digital Imaging and Communication in Medicine (DICOM), which simplifies the process of identifying pathologies or diseases.
  • The new tool processes and annotates medical data provided by pharmaceutical and biotechnology organizations that utilize artificial intelligence.
  • Pharmaceutical, biotechnology and medical device sponsors as well as pathology and diagnostic companies can partner with DataForce to label their datasets and train machine learning models used in applications such as early pathology detection, fast diagnostics, and accelerated product development.
  • With its rapidly emerging demand and 80% of clinical solutions providers supporting use cases to this end, DataForce serves as an essential mechanism for deep learning AI to minimize data errors by accessing various data points simultaneously.

Eastwall and Efferent Health partner to provide comprehensive Microsoft Azure Cloud services for medical imaging & healthcare informatics customers

Retrieved on: 
Wednesday, September 27, 2023

DENVER, Sept. 27, 2023 /PRNewswire/ -- Eastwall, an emerging leader in pureplay Microsoft Azure Consulting and Engineering, and Efferent Health, a leading innovator in healthcare data informatics and medical imaging, are pleased to announce a partnership to enhance services provided to its customers on Microsoft Azure.

Key Points: 
  • DENVER, Sept. 27, 2023 /PRNewswire/ -- Eastwall, an emerging leader in pureplay Microsoft Azure Consulting and Engineering, and Efferent Health, a leading innovator in healthcare data informatics and medical imaging, are pleased to announce a partnership to enhance services provided to its customers on Microsoft Azure.
  • Efferent Health will provide their innovative cloud based DHP (Digital Health Platform) solutions to optimize DICOM (Digital Imaging and Communications in Medicine) workflow management, HL7®, FHIR® (Fast Healthcare Interoperability Resources), and workflow automation.
  • The collaboration between Eastwall and Efferent Health will significantly enhance service offerings for medical imaging and healthcare informatics customers, streamlining the migration to cloud architecture and their subsequent cloud journey.
  • It creates a collaborative synergy that elevates how our medical imaging informatics clients integrate our software in the cloud."

CitiusTech and Radical Imaging Partner to Support Open Health Imaging Foundation Development Projects

Retrieved on: 
Monday, August 7, 2023

Ltd. , a leading provider of healthcare technology services, solutions, and platforms, today announced its partnership with Radical Imaging LLC, a pioneer in medical imaging informatics, interoperability, and integrations, to offer comprehensive services for both companies to support development projects built on the Open Health Imaging Foundation (OHIF) open-source web imaging platform.

Key Points: 
  • Ltd. , a leading provider of healthcare technology services, solutions, and platforms, today announced its partnership with Radical Imaging LLC, a pioneer in medical imaging informatics, interoperability, and integrations, to offer comprehensive services for both companies to support development projects built on the Open Health Imaging Foundation (OHIF) open-source web imaging platform.
  • The partnership combines the project management, user experience design, and product testing experience of the MGH group with the software development and system design expertise of Radical Imaging.
  • Now, we will be able to satisfy the staffing requirements that are necessary for us to take on the largest medical imaging software projects," said Rob Lewis, CEO of Radical Imaging.
  • With CitiusTech, Radical Imaging will be able to commit to new medical imaging software development projects that will help the company grow.